Market Place
Sourcing Support
Teva`s IMPACT-TD Real-World Data On Tardive Dyskinesia At Psych Congress
01 Jun 2024 //
BUSINESSWIRE
Teva`s AUSTEDO® XR Approved As Once-Daily ADHD Treatment Option
29 May 2024 //
BUSINESSWIRE
Teva Reports First Quarter 2024 Financial Results and Reaffirms 2024
08 May 2024 //
PRESS RELEASE
Teva: AUSTEDO® RWE Confirms Efficacy, Satisfaction In HD Chorea
16 Apr 2024 //
BUSINESSWIRE
Teva to Present New Data Supporting Safety of AUSTEDO Tablets
02 Nov 2023 //
BUSINESSWIRE
Aurobindo Pharma`s Generic Deutetrabenazine Receives Approval in the U.S.
26 Sep 2023 //
FDA
Teva to Present Data for AUSTEDO Extended-Release Tablets, AUSTEDO Tablets
06 Sep 2023 //
BUSINESSWIRE
Teva Presents Real-World Data for AUSTEDO Tablets
02 Jun 2023 //
BUSINESSWIRE
AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, AUSTEDO®
15 May 2023 //
BUSINESSWIRE
Teva to Present data on Once-Daily AUSTEDO XR Extended-Release Tablets
11 Apr 2023 //
BUSINESSWIRE
Teva`s flagship drug Austedo scores new approval at the FDA
22 Feb 2023 //
FIERCE PHARMA
Teva Announces FDA Approval of AUSTEDO Extended-Release Tablets
17 Feb 2023 //
BUSINESSWIRE
Teva leans on Ajovy and Austedo as revenues sink
08 Feb 2023 //
FIERCE PHARMA
Teva walks away from PhRMA after similar move by AbbVie
04 Feb 2023 //
FIERCE PHARMA
Teva Announces Results from Safety and Tolerability of AUSTEDO Tablets
18 Oct 2022 //
BUSINESSWIRE
Teva Announces Settlement with Aurobindo Resolving AUSTEDO Patent Dispute
09 Jun 2022 //
BUSINESSWIRE
Teva to Present New Analyses of AJOVY Injection and AUSTEDO Tablets at 2022 AAN
01 Apr 2022 //
BUSINESSWIRE
Teva`s Austedo struggling from pandemic slowdown; All eyes on Q4
27 Oct 2021 //
FIERCEPHARMA
Teva to Present New Data from Growing Mental Health Portfolio at Psych
21 Oct 2021 //
BUSINESSWIRE
Teva launches first DTC for Austedo into competitive market
29 May 2021 //
FIERCE PHARMA
Teva to Present New Analyses of AUSTEDO® (deutetrabenazine)
27 Apr 2021 //
BUSINESSWIRE
Teva to Present New Data on AUSTEDO (deutetrabenazine) Tablets
08 Sep 2020 //
BIOSPACE
New Data For Teva AJOVY® (fremanezumab-vfrm) Injection and AUSTEDO®
01 May 2020 //
BUSINESSWIRE
Teva’s weak pipeline hit by Tourette’s drug trial failure
21 Feb 2020 //
PMLIVE
Teva Announces Registration Trials of Deutetrabenazine in Pediatric Patients
19 Feb 2020 //
BUSINESSWIRE
Global cutbacks done, Teva aims to grow with Ajovy, Austedo
12 Feb 2020 //
FIERCE PHARMA
Teva stops testing its migraine drug as cluster headache treatment
24 Apr 2019 //
REUTERS
JPM recap: Must-reads of the week, from FDA to IPO to M&A
12 Jan 2019 //
FIERCE PHARMA
As Teva`s Austedo gets more play, doctors are coming around
11 Jun 2018 //
FIERCE PHARMA
